Influence of interferon β-1a dose frequency on PBMC cytokine secretion and biological effect markers
- 1 September 1999
- journal article
- clinical trial
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 99 (1) , 131-141
- https://doi.org/10.1016/s0165-5728(99)00029-6
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Management of Multiple SclerosisNew England Journal of Medicine, 1997
- Distinct STAT Structure Promotes Interaction of STAT2 with the p48 Subunit of the Interferon-α-stimulated Transcription Factor ISGF3Journal of Biological Chemistry, 1997
- Increased CD80(+) B cells in active multiple sclerosis and reversal by interferon beta-1b therapy.Journal of Clinical Investigation, 1997
- Autoimmune Pathogenesis of Multiple Sclerosis: Role of Autoreactive T Lymphocytes and New Immunotherapeutic StrategiesCritical Reviews in Immunology, 1997
- Pharmacokinetics and Pharmacodynamics of Recombinant Human Interferon-β in Healthy Male VolunteersJournal of Interferon & Cytokine Research, 1996
- Interferon effects on interleukin-10 secretion Mononuclear cell response to interleukin-10 is normal in multiple sclerosis patientsJournal of Neuroimmunology, 1995
- Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor‐immunoglobulin fusion proteinsEuropean Journal of Immunology, 1994
- Clinical Toxicity of the InterferonsDrug Safety, 1994
- Interferon β decreases T cell activation and interferon γ production in multiple sclerosisJournal of Neuroimmunology, 1993
- Highly Sensitive Enzyme Immunoassay of Human Interferon-β1Journal of Immunoassay, 1989